Live Webinar
Advances in cell and gene therapy are expanding the therapeutic frontier in oncology and immune modulation, but overcoming barriers such as limited persistence, antigen escape, and the immunosuppressive tumor microenvironment remains a key challenge. In this Biocompare webinar, two experts in the field—Yvonne Chen (University of California, Los Angeles) and Ellen Puré (University of Pennsylvania)—will discuss the next generation of mechanistic and translational strategies that are shaping how these therapies are designed and optimized.
Dr. Chen, known for her work on synthetic CAR T-cell architectures, will explore how rational design, combinatorial signaling, and control circuits can enhance safety and efficacy. Dr. Puré will share insights into stromal–immune crosstalk within the tumor microenvironment and how stromal modulation can potentiate durable therapeutic responses.
What you’ll learn in this webinar:
- Strategies for optimizing CAR T-cell function through synthetic design and modular control elements.
- Mechanistic understanding of the stromal and immune cell interactions that limit CAR T efficacy.
- Approaches to integrate next-generation molecular engineering with translational immunology.
- Emerging opportunities to bring cell and gene therapies closer to clinical and commercial success.
Register today to gain valuable insights into how two leading labs are bridging molecular innovation with clinical translation to advance cell and gene therapies.
Offered Free by: Biocompare
See All Resources from: Biocompare
